MEDICSKIN Forecasts Annual Profit Between 500,000 and 1.5 Million Hong Kong Dollars, Reversing Previous Loss

Stock News
06/12

The company anticipates recording a consolidated profit attributable to its owners in the range of approximately HK$500,000 to HK$1.5 million for the fiscal year ending March 31, 2026. This represents a significant turnaround from the net loss of about HK$3.4 million attributable to owners reported for the corresponding period in the previous year.

The board attributes this shift from loss to profitability primarily to two key factors. Firstly, the group's revenue for the year ending March 31, 2026, has increased compared to the prior year. This growth is credited to a rise in the number of clients using its treatment services and an increase in client visits for these services.

Secondly, the company achieved cost savings during the period. These savings included a reduction in rental expenses, which consequently lowered the depreciation of right-of-use assets, and a decrease in employee-related costs.

免责声明:投资有风险,本文并非投资建议,以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请,作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考,不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证,投资者应自行研究并在投资前寻求专业建议。

热议股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10